Quantcast

Industry news that matters to you.  Learn more

Drugscreen.com Introduces New K2 Screening With Advanced Detection Capability

Drugscreen.com, announced today the introduction of its advanced screening process for the detection of K2 (synthetic marijuana) through a highly efficient test. Drugscreen.com, a division of SECON, has demonstrated that the new process can identify many of the new synthetic cannabinoid compounds being sold on the street today, making it highly successful in detecting the presence of the drug as compared to previous drug screening protocols.